Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 9,212,228
🏛 Food and Drug Administration (FDA)FDA-2025-E-0863
Documents
1
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.